D. Western Therapeutics Institute, Inc. (4576.T)
JPY 233.0
(14.22%)
JPY 233.0
(14.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 428.36 Million | 448.1 Million | 414.42 Million | 355.58 Million | 580.52 Million |
| Cost of Revenue | 36.66 Million | 27.56 Million | 20.09 Million | 17.01 Million | 70.04 Million |
| Gross Profit | 391.69 Million | 420.53 Million | 394.32 Million | 338.56 Million | 510.48 Million |
| Operating Expenses | 1.14 Billion | 726.44 Million | 565.97 Million | 604.24 Million | 393.16 Million |
| Selling, General and Administrative Expenses | 258 Million | 255 Million | 248 Million | 253 Million | 143.8 Million |
| Research and Development Expenses | 930.5 Million | 469.56 Million | 316.16 Million | 350.53 Million | 249.36 Million |
| Other Expenses | - | -8.33 Million | 127 Thousand | -3.71 Million | - |
| Cost and Expenses | 1.22 Billion | 754.01 Million | 586.07 Million | 621.26 Million | 463.21 Million |
| Operating Income | -798.55 Million | -305.91 Million | -171.64 Million | -265.67 Million | 117.31 Million |
| Interest Expense | 2.49 Million | 3.14 Million | 4.42 Million | 4.72 Million | 5.87 Million |
| Income Tax Expense | 1.59 Million | 1.59 Million | 1.59 Million | 1.59 Million | 1.59 Million |
| Earnings before Tax | -826.8 Million | -440.26 Million | -159.71 Million | -289.52 Million | 109.57 Million |
| Net Income | -812.41 Million | -429.68 Million | -148.99 Million | -276.1 Million | 133.2 Million |
| Earnings Per Share Basic | -25.56 | -14.50 | -5.08 | -10.16 | 5.07 |
| Earnings Per Share Diluted | -25.56 | -14.50 | -5.08 | -10.16 | 5.07 |
| Weighted Average Shares Outstanding | 31.78 Million | 29.63 Million | 29.33 Million | 27.17 Million | 26.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.78 Million | 29.63 Million | 29.33 Million | 27.17 Million | 26.27 Million |
| Gross Margin | 0.91 | 0.94 | 0.95 | 0.95 | 0.88 |
| EBIT Margin | -1.81 | -0.55 | -0.27 | -0.68 | 0.28 |
| Profit Margin | -1.90 | -0.96 | -0.36 | -0.78 | 0.23 |
| EBITDA | -775.59 Million | -390.75 Million | -110.02 Million | -240.63 Million | 161.5 Million |
| Earnings Before Tax Margin | -1.86 | -0.68 | -0.41 | -0.75 | 0.20 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 118.7 Million | 104.81 Million | 114.37 Million | 428.36 Million | 126.28 Million | 97.71 Million |
| Cost of Revenue | 21.81 Million | 9.12 Million | 8.93 Million | 36.66 Million | 13.03 Million | 7.36 Million |
| Gross Profit | 96.88 Million | 95.69 Million | 105.43 Million | 391.69 Million | 113.25 Million | 90.34 Million |
| Operating Expenses | 227.93 Million | 414.48 Million | 446.35 Million | 1.19 Billion | 312.53 Million | 247.61 Million |
| Selling, General and Administrative Expenses | 53.39 Million | 68 Million | 60 Million | - | 61 Million | 67 Million |
| Research and Development Expenses | 174.53 Million | 346.86 Million | 384.89 Million | - | 250.86 Million | 181.57 Million |
| Other Expenses | -951 Thousand | -3.43 Million | -140 Thousand | -642 Thousand | -216 Thousand | -125 Thousand |
| Cost and Expenses | 249.75 Million | 423.61 Million | 455.29 Million | 1.22 Billion | 325.56 Million | 254.97 Million |
| Operating Income | -131.05 Million | -318.79 Million | -340.92 Million | -798.55 Million | -199.28 Million | -157.26 Million |
| Interest Expense | 1.23 Million | 869 Thousand | 674 Thousand | 2.49 Million | 591 Thousand | 599 Thousand |
| Income Tax Expense | 399 Thousand | 398 Thousand | 399 Thousand | 1.59 Million | 399 Thousand | 399 Thousand |
| Earnings before Tax | -199.44 Million | -320.45 Million | -372.85 Million | -826.8 Million | -199.35 Million | -153.26 Million |
| Net Income | -199.84 Million | -320.85 Million | -368.49 Million | -812.41 Million | -195.93 Million | -150.12 Million |
| Earnings Per Share Basic | -6.02 | -9.99 | -11.47 | - | -6.11 | -4.73 |
| Earnings Per Share Diluted | -6.02 | -9.99 | -11.47 | - | -6.11 | -4.73 |
| Weighted Average Shares Outstanding | 33.17 Million | 32.12 Million | 32.13 Million | 31.78 Million | 32.09 Million | 31.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.17 Million | 32.12 Million | 32.13 Million | 31.78 Million | 32.09 Million | 31.71 Million |
| Gross Margin | 0.82 | 0.91 | 0.92 | 0.91 | 0.90 | 0.92 |
| EBIT Margin | -1.00 | -3.05 | -3.25 | - | -1.57 | -1.56 |
| Profit Margin | -1.68 | -3.06 | -3.22 | -1.90 | -1.55 | -1.54 |
| EBITDA | -118.63 Million | -319.58 Million | -372.18 Million | - | -198.76 Million | -152.66 Million |
| Earnings Before Tax Margin | -1.10 | -3.04 | -2.98 | -1.86 | -1.58 | -1.61 |
MORG
BESIY
000503
MCR
3150
300580